Contact

Flashwave®

Max-Stromeyer-Str. 116

78467 Konstanz, Germany

1/2

DIABETES FACTS according to the WHO's website

  • The number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014.

  • The global prevalence of diabetes among adults over 18 years of age has risen from 4.7 % in 1980 to 8.5 % in 2014.

  • Diabetes prevalence has been rising more rapidly in middle- and low-income countries.

  • Diabetes is a major cause of blindness, kidney failure, heart attacks, stroke and lower limb amputation.

  • In 2012, an estimated 1.5 million deaths were directly caused by diabetes and another 2.2 million deaths were attributable to high blood glucose.

  • Almost half of all deaths attributable to high blood glucose occur before the age of 70 years.

  • WHO projects that diabetes will be the 7th leading cause of death in 2030.

Where does Flashwave® help treat DIABETES related complications?

  • Diabetic Foot Syndrome (DFS)

  • Chronic wounds on patients with DFS

  • Diabetes related desensitizing of extremities

  • Diabetes related erectile dysfunction


With the unique Flashwave® technology even severely affected areas can be treated comfortably, it’s bespoke CCI® allowing easy access, a high degree of accuracy and short treatment time.


Flashwave® as Biocellular Transductive Wave Therapy activates cellular communication, leading to an increase in perfusion and arteriogenesis, biofilm disruption, a pro-inflammatory response, cytokine and chemokine effects, growth factor upregulation, angiogenesis and the subsequent regeneration of tissue such as skin, musculoskeletal and vascular structures.

Flashwave® technology is highly effective across a wide range of medical applications. The ability to communicate with different cells allows for treatment and management of vastly different diabetes-related medical
indications, as Biocellular Transductive Wave Therapy counteracts the typical complications caused by diabetes, such as reduced blood flow, neuropathy and vascular disease.


As little as three Flashwave® treatments may suffice to show significant improvement in the aforementioned diabetes-related complications, no matter how long the patient has been suffering from them before the treatment.

 

Flashwave® benefits in

DIABETES-RELATED INDICATIONS

 

  • Offers a cure for DFS, not just a slowdown of the progression

  • It’s a non-invasive treatment

  • Easy to apply

  • Short treatment duration

  • Based on cellular communication – triggers the body’s natural repair mechanism

  • Light, compact and mobile

 

Diabetes and diabetes related medical complications are among the most serious medical concerns facing our societies. Treatment of diabetes related indications is a constantly growing expense, especially since many of the diabetes related symptoms are currently incurable. Diabetes mellitus is becoming one of the most chronic diseases of our times.